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Endovascular aortic aneurysm repair with carbon
dioxide-guided angiography in patients with renal
insufficiency
Enrique Criado, MD, Gilbert R. Upchurch Jr, MD, Kate Young, MSRS, John E. Rectenwald, MD,
Dawn M. Coleman, MD, Jonathon L. Eliason, MD, and Guillermo A. Escobar, MD, Ann Arbor, Mich
Objective: Renal dysfunction following endovascular abdominal aortic aneurysm repair (EVAR) remains a significant
source of morbidity and mortality. We studied the use of carbon dioxide (CO2) as a non-nephrotoxic contrast agent for
EVAR.
Methods: Recorded data from 114 consecutive patients who underwent EVAR with CO2 as the contrast agent over 44
months were retrospectively analyzed. CO2 was used exclusively in 72 patients and in an additional 42 patients iodinated
contrast (IC) was given (mean, 37 mL). Renal and hypogastric artery localization and completion angiography were done
with CO2 in all patients, including additional arterial embolization in 16 cases. Preoperative National Kidney Foundation
glomerular filtration rate (GFR) classification was normal in 16 patients, mildly decreased in 52, moderate to severely
decreased in 44, and two patients were on dialysis.
Results: All graft deployments were successful with no surgical conversions. CO2 angiography identified 20 endoleaks
(two type 1, 16 type 2, and two type 4) and three unintentionally covered arteries. Additional use of IC in 42 patients did
not modify the procedure in any case. When compared with a cohort of patients who underwent EVAR using exclusively
IC, the operative time was shorter with CO2 (177 vs 194 minutes; P .01); fluoroscopy time was less (21 vs 28 minutes;
P  .002), and volume of IC was lower (37 vs 106 mL; P < .001). Postoperatively, there were two deaths, two instances
of renal failure requiring dialysis, and no complications related to CO2 use. Among patients with moderate to severely
decreased GFR, those undergoing EVAR with IC had a 12.7% greater decrease in GFR compared with the CO2 EVAR
group (P  .004). At 1, 6, and 12-month follow-up, computed tomography angiography showed well-positioned
endografts with the expected patent renal and hypogastric arteries in all patients and no difference in endoleak detection
compared with the IC EVAR group. During follow-up, eight transluminal interventions and one open conversion were
required, and no aneurysm-related deaths occurred.
Conclusions: CO2-guided EVAR is technically feasible and safe; it eliminates or reduces the need for IC use, may expedite
the procedure, and avoids deterioration in renal function in patients with pre-existing renal insufficiency. A prospective
trial comparing CO2 with IC during EVAR is warranted. (J Vasc Surg 2012;55:1570-6.)
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EThe amount of iodinated contrast (IC) media injected
during catheter-based procedures involving the renal arter-
ies has been shown to have a strong correlation with a
decrease in creatinine clearance following intervention in
prospective, randomized trials.1 The perioperative use of
IC agents is likely an important cause of renal dysfunction
following endovascular abdominal aortic aneurysm repair
(EVAR).2 Therefore, its avoidance should be beneficial in
patients with pre-existing renal insufficiency and possibly in
any patient undergoing EVAR. Carbon dioxide (CO2) has
no known nephrotoxicity and has a proven record of safety
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1570nd technical viability as an alternative to IC agents during
ll types of vascular intervention.3 Encouraged by our
nitial experience with CO2 angiography with a novel tech-
ique for EVAR, we expanded the use of CO2 in our EVAR
ractice.4 This study describes the technical results and
ffects on renal function on 114 consecutive patients who
nderwent EVAR with CO2 as a contrast agent and a
omparison with a cohort of EVAR cases performed exclu-
ively with IC.
ETHODS
During a 44-month period, 114 consecutive patients
mean age, 72 years; range, 49-93 years; 94 males; mean
neurysm diameter, 58 mm) underwent EVAR using CO2
s the intended contrast agent for angiographic localization
f the aortic and iliac landing zones for endograft deploy-
ent, for guidance of additional endovascular procedures,
nd for completion angiography. These were consecutive
atients and were not preselected for CO2 angiography.
ne hundred ten cases were elective repairs and four were
uptured, emergency cases that have been the subject of a
revious report.5 Two patients on dialysis underwent
VAR with CO because it is the first author’s (E.C.)2
tandard technique for EVAR in all cases, regardless of renal
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Volume 55, Number 6 Criado et al 1571function. These two cases were used for technical compar-
isons but not for estimation of changes in renal function.
CO2was used exclusively in 72 patients, and in an addi-
tional 42 patients Iodixanol 270 (Visipaque; GE Health-
care, Princeton, NJ) was used as a contrast agent at the
discretion of the attending surgeon (mean, 37 mL per case;
range, 3-103 mL). In 31 patients, additional procedures
were performed, including 23 endoluminal procedures (12
hypogastric artery embolizations, six iliac transluminal an-
gioplasties or recannalizations, three inferior mesenteric
artery embolizations, one accessory renal artery emboliza-
tion, and one superior mesenteric artery stenting) and eight
open procedures (five femoro-femoral bypasses and three
femoral endarterectomies).
Patients were followed with physical examination and
enhanced computerized tomography (CT) at 1, 6, and 12
months, and yearly thereafter. Patients with renal insuffi-
ciency were followed with ultrasound and CT without
contrast. Estimation of glomerular filtration rate (eGFR)
was expressed in mL/min/1.73 m2 and calculated based
on the formula recommended by the National Kidney
Foundation (NKF) Practice Guidelines (186 x (plasma
creatinine)-1.154 x (age)-0.203 x (0.742 if female) x (1.210 if
African American)).
Preoperative renal function and IC allergy status.
Mean preoperative eGFR and creatinine levels were 65
mL/min (range, 8-133 mL/min) and 1.4 mg/dL (range,
0.5-8.5 mg/dL), respectively. Before surgery, according to
the NKF classification for chronic kidney disease based on
eGFR, 16 patients had normal eGFR (90 mL/min), 52
had mildly decreased eGFR (60-89 mL/min), 40 had
moderately decreased eGFR (30-59 mL/min), four had
severely decreased eGFR (15-29 mL/min), and two were
in kidney failure and on dialysis. In addition, 22 patients
were diabetics, six had a single kidney, and two had a renal
transplant. A severe contrast allergy was documented in
nine patients. The patients on dialysis were not included in
the statistical comparisons.
Cohorts of patients undergoing EVAR exclusively
with IC. A contemporary cohort of 22 comparable pa-
tients undergoing EVAR exclusively with IC was used to
record the operative time (193 10min, mean standard
deviation [SD]), total fluoroscopy time (28 min, SD  1
min), total volume of IC used (106 6 mL, mean SD),
and postoperative endoleak detection. A separate cohort of
50 patients with pre-existing moderately decreased eGFR
(30-59 mL/min) to severely decreased eGFR (15-29 mL/
min) with a mean eGFR of 39  12.4 mL/min, mean 
SD) was used to compare the postoperative changes in
eGFR (2.3  29 mL/min, mean  SD) with that of the
CO2 EVAR group.
Preprocedural imaging and endograft selection.
Thin-slice CT scanning and three-dimensional reconstruc-
tion (3D-CT) of the abdominal aortoiliac segment was
done preoperatively in all patients, except in the ruptured
cases that were evaluated without 3D reconstructions. In
six patients with significant renal insufficiency, a CT scan
without contrast followed by intraoperative CO2 angiogra- lhy was done for endograft selection. Based on the CT
nformation, endografts were selected for implantation
ased on the patient’s anatomy and the surgeon’s prefer-
nce, including 97 Zenith Flex aortic endografts (Cook
edical Inc, Bloomington, Ind), 10 AneuRx (Medtronic
nc, Minneapolis, Minn), five Excluder (W. L. Gore &
ssociates Inc, Flagstaff, Ariz), and two Aortofix (Lom-
ard, Sunnyvale, Calif).
Interventional technique. All endograft placements
ere done with fixed C-arm fluoroscopic imaging (AXIOM
rtis dTA; Siemens AG, München, Germany). In 62 cases,
e used a previously described technique for endograft
eployment injecting CO2 though the endograft delivery
heath, and in 52, the procedure was done with an end-hole
atheter or angiographic catheter for CO2 injection using
he following technique.
The femoral arterieswere exposed throughbilateral short,
blique incisions placed just caudal to the inguinal ligaments.
tiff shaft glidewires (Terumo Medical Co, Somerset, NJ)
ere advanced into the suprarenal aorta under fluoroscopic
uidance from both femoral sides, and 9-F, 11-cm-long
heaths were placed over the wire, and the glidewire was
xchanged for a Lunderquist Extra Stiff Guidewire (Cook
edical Inc) or similar wire, and its tip placed in the proximal
escending thoracic aorta from the side selected for main
ody deployment. The patient was given systemic heparin.
rom the contralateral side, a 5-F, 65-cm-long angled tip
lide catheter was placed over the wire at the level of the first
ig 1. Under fluoroscopic guidance, the main body of the en-
ograft delivery sheath is advanced into the aorta, and the proximal
tent is placed at the estimated level of the renal arteries. From the
ontralateral side, the tip of a 5-F angled glide catheter is placed at
he same aortic level to initiate the angiographic procedure. Note
hat this patient had a pre-existing left renal artery stent.umbar vertebral body. The endograft main body was ad-
o
l
a
w
a
5
a
fi
fi
A
f
s
O
w
u
v
t
f
m
a
e
P
R
F
t
l
i
d
t
o
JOURNAL OF VASCULAR SURGERY
June 20121572 Criado et alvanced over the extra-stiff wire, until the proximal stent was in
the perirenal aorta (Fig 1). A 60-mL Luer-lock syringe con-
nected to the CO2 delivery system (Angio Flush III Contrast
Management System; Angio Dynamics Inc, Queensbury,
NY) was used for all CO2 hand injections. Catheters were
purgedwith 5 to 10mLofCO2 prior to bolus injections. This
purging maneuver facilitates smooth, nonexplosive CO2 de-
livery during intravascular angiographic injection. Ventilation
motion was held and, using the CO2 subtraction settings, an
aortogram was obtained using 40 mL of CO2 hand-injected
over approximately 2 seconds. The renal arteries were visual-
ized, and the optimal subtraction image is stored for guidance
during endograft deployment (Fig 2). The main body of the
graft was deployed based on this angiogram. If a renal artery
was not visualized, the table was tilted to elevate the kidney,
which facilitates passage of CO2 into the renal artery. It is
important to bear in mind that the CO2 bubble is highly
buoyant and accumulates in the most superior portion of the
arterial segment. Next, the contralateral docking limb was
cannulated in a retrograde fashion. A retrograde angiogram
was obtained in an anterior oblique projection, injecting 30
mL of CO2 through the contralateral femoral sheath to local-
ize the origin of the hypogastric artery (Fig 3). The contralat-
Fig 2. With digital subtraction technique in carbon dioxide
(CO2) settings, using a 60-mL syringe, 40 mL of CO2 are injected
by hand in approximately 2 seconds through the angled glide
catheter and an aortogram is obtained. Note the clear opacification
of the renal arteries, which serve for guidance in the deployment of
the main body of the endograft. During this sequence, the aortic
bifurcation is also visualized.eral limb of the graft was then deployed proximal to the origin uf the hypogastric artery. The ipsilateral hypogastric arterywas
ocalized by retrograde injection of 30 mL of CO2 in the
nterior oblique projection (Fig 4), and the ipsilateral limb
as deployed. Once the endograft was shaped with a compli-
nt balloon, a completion angiogram was done through the
-F angled glide, end-hole catheter, injecting 40 mL of CO2
nd including the renal and hypogastric artery origins in the
eld. The subtraction sequence was held to allow late opaci-
cation of the lumbar and inferior mesenteric arteries (Fig 5).
dditional injections were obtained with the catheter in dif-
erent positions or in different projections, if there was any
uggestion of endoleak or other potential problem (Fig 6).
nce a satisfactory angiogram was obtained, the procedure
as completed in a standard fashion.
Statistical analysis. Statistical analysis was performed
sing PASW 18 software (SPSS, Chicago, Ill). Continuous
ariables between two groups were compared using Student’s
-test and comparisons between categorical values were per-
ormed using 2 analysis. Any comparisons between two or
ore groups were performed with one-way analysis of vari-
nce. All data are presented as the mean value the standard
rror of the mean, unless otherwise stated. Comparisons with
values.05 were considered significant.
ESULTS
During a 44-month period, 114 consecutive patients
ig 3. Following deployment of the main body of the endograft,
he contralateral docking limb is retrogradely cannulated, and the
eft hypogastric artery is localized by obtaining a pelvic angiogram
n the right anterior oblique projection, injecting 30 mL of carbon
ioxide (CO2) retrogradely through the left femoral sheath. Note
he angiographic detail offered by CO2 depicting a stenosis of the
rigin of the left hypogastric artery.nderwent EVAR using CO2 as the intended contrast
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conversions to open repair. The mean volume of CO2 used
for EVAR in 114 patients was 395 mL (range, 80-780 mL)
with a mean number of 11 CO2 angiographic runs per
intervention. The mean total procedural time was 177
minutes. In 72 patients, the EVAR and all ancillary translu-
minal procedures were completed using exclusively CO2 as
the contrast agent (mean, 389  17 mL of CO2 per case)
with a mean fluoroscopy time of 21  1.2 minutes and a
mean total procedural time of 165  6 minutes. In 42
patients, where the attending surgeon deemed it necessary
to use IC (mean, 37  3.7 mL per case; range, 3-103 mL)
in addition to CO2 (mean, 430  29 mL per case), the
mean fluoroscopy time was 32 3.2 minutes, and the total
procedural time was 193  9 minutes. The reasons for the
use of additional IC were to visualize renal arteries or other
branches not well seen with CO2 alone, or to confirm the
presence of endoleak suspected by CO2 angiography.
Intraoperatively, three arteries were unintentionally
covered by the endograft; this included one hypogastric
and two renal arteries. One of the renal arteries was re-
opened by applying traction on the body of the endograft,
but this vessel thrombosed within 24 hours. The other two
vessels were left covered. The coverage of these vessels was
not due to inadequate visualization. It was due to short
Fig 4. Following deployment of the contralateral limb of the
endograft, a pelvic angiogram is obtained in the left anterior
oblique projection, and a 30-mL injection of carbon dioxide
(CO2) through the right femoral sheath is placed after removal of
the main-body delivery system. Alternatively, CO2 may be injected
through the side port of the ipsilateral limb delivery sheath, ad-
vanced into the external iliac artery, saving a sheath exchange step.
Note that this pelvic angiogram is shown without subtraction, still
providing excellent anatomical detail of the iliac bifurcation and
the internal iliac artery branches.infrarenal necks in case of the renal arteries, and to a iiscalculation of graft length in the case of the hypogastric.
ompletion CO2 angiography identified 20 endoleaks
two type 1, 16 type 2, and two type 4). No additional
ndoleaks were detected with the intraoperative use of IC.
t 1 month of follow-up, no additional type 1 or type 3
ndoleaks were detected by CT or ultrasound.
When compared with the cohort of 22 patients who
nderwent EVAR exclusively with IC, the operative time
as shorter in the CO2 group (177  7 min vs 193  10
in; P .01), fluoroscopy time was less (21 1min vs 28
min; P .002), and the volume of IC used was less (37 4
L vs 106 7 mL; P .001).
Four patients returned to the operating roomwithin 24
ours: two for femoral artery thrombosis, one for a type 1
ndoleak identified intraoperatively, and one for a renal
rtery thrombosis secondary to encroachment of the orifice
y the endograft. There were two postoperative deaths,
esulting in a 1.7% 30-day mortality: one patient with
dvanced congestive heart failure who refused further treat-
ent, and the second patient with a preoperative creatinine
learance of 17 mL/min, who required dialysis following
urgery, and opted for hospice care.
During follow-up at 1 to 39months, eight transluminal
ig 5. The completion angiogram is done with the angled glide
atheter in the perirenal aorta. The fluoroscopic sequence is held to
llow late opacification of lumbars and inferior mesenteric artery. It
s important to bear in mind that carbon dioxide (CO2) opacifies
he arterial branches much faster than iodinated contrast (IC).
ote that this angiogram depicts the renal arteries, the superior
esenteric artery with all its branches, and several lumbar arteries
een without opacification of the aneurysmal sac. Both hypogastric
rteries are patent in the image.nterventions and one open conversion were required, with
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never returned for follow-up, and 12 died from causes not
related to EVAR.
At 1, 6, and 12 months, imaging studies revealed
well-positioned endografts with the expected patent renal
and hypogastric arteries in all patients and no difference in
endoleak detection compared with the IC EVAR group.
Renal function results in patients with moderate/
severe renal insufficiency. Preoperatively, there was no
significant difference in the baseline GFR between the
groups of patients with pre-existing renal insufficiency per-
formed exclusively with CO2 (41  11 mL/min), those
done with CO2 and IC (43 11mL/min), and the cohort
group done with IC only (39  12 mL/min).
Following surgery, among patients with moderate to
severely decreased GFR, the cohort group who underwent
EVAR exclusively with IC had a 12.7% greater decrease in
GFR compared with the EVAR group done with CO2 with
or without additional IC (P  .004) and a 10% greater
decrease in GFRwhen compared with the group of patients
who had EVAR done exclusively with CO2 (P  .042).
Two patients required dialysis during the immediate
postoperative period. One of them had a preoperative GFR
of 17 mL. The second patient required dialysis after going
into acute heart failure on the second postoperative day.
Two patients developed dialysis requirements during the
Fig 6. An additional oblique projection shows all the visceral
vessels, a stenosis in the left renal stent, and retrograde opacifica-
tion of the inferior mesenteric artery via the left colic and superior
hemorrhoidal arteries, but without passage of carbon dioxide
(CO2) into the aneurysmal sac. The postoperative computerized
tomography (CT) scan confirmed the absence of endoleaks in this
patient.follow-up period. One patient had polycystic kidney disease Cith a preoperative creatinine level greater than 6 mg/dL.
he second patient had a solitary, partially resected kidney
nd a baseline creatinine of 4.7 mg/dL; this patient went
n to require peritoneal dialysis 3 years following EVAR.
ISCUSSION
Renal failure following EVAR remains a source of
orbidity and mortality in the immediate postoperative
eriod and during long-term follow-up of these patients.2
rogression of renal dysfunction following EVAR appears
o be related to multiple factors, including the use of IC
edia in the perioperative and postoperative period. The
dministration of IC media to patients undergoing EVAR
s perhaps the only factor contributing to renal dysfunction
hat could be completely avoided, simply by avoiding its
se. The purpose of an intravascular contrast agent during
VAR is to localize themajor branches of the aorta and iliac
rteries to allow precise deployment of the endograft, and
pon completion, to identify significant endoleaks and ascer-
ain patency of the graft, renal arteries, and outflow vessels.
CO2, as a contrast agent, provides all this information,
ith the advantages that it has no known renal or systemic
oxicity, is not allergenic, is widely available in the hospital
nvironment at an extremely low cost, and when used with
he adequate knowledge and technique is an extremely safe
egative contrast agent.6 The technical suitability of CO2
ngiography for EVAR and its beneficial effect on preser-
ation of renal function have been suggested during the last
ecade in several publications.4,7,8 However, the use of
O2 for EVAR guidance remains anecdotal considering
he large number of cases annually performed.
Vascular surgeons have traditionally been trained ex-
lusively in the use of IC media for transluminal interven-
ion, and very few are familiar with the use of alternative
ontrast agents. This is most likely the reason for the
otable paucity of publications in which CO2 angiography
as used for EVAR guidance.
In patients with pre-existing renal insufficiency or se-
ere allergy to IC, it is advisable, if not mandatory, to use
lternative, non-nephrotoxic or nonallergenic guiding
ethods for EVAR. As such, intravascular ultrasound
IVUS) and transabdominal ultrasound have been techni-
ally successful and have also suggested that reducing the
mount of IC use during EVAR decreases the deterioration
n renal function following intervention.9,10 However,
VUS has failed to gain popularity perhaps due to its
echnical complexity, cost, and limited availability in many
urgical centers.
Our experience using CO2 as a contrast agent for EVAR
n unselected patients resulted in no intraoperative mortality,
o conversions to open repair, no failures to identify type 1 or
ype 3 endoleaks, a very low number of immediate reopera-
ions, and a low reintervention rate during follow-up. Our
esults are comparable with those reported in large trials using
C and performed under optimal conditions in well-selected
atients. Furthermore, it is important to note that our expe-
ience includes the learning curve of several surgeons using the
O2 technique, which implies that our results could be im-
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Volume 55, Number 6 Bismuth 1575proved with more experience. The shorter operative time for
CO2-guided EVAR compared with EVAR done with ICmay
be a result of the avoidance of power injection, which may
shorten the overall duration of the procedure, as hand injec-
tion of CO2 is faster compared with power injection. This
difference, however, may just represent individual practice
because the majority of the CO2 EVAR cases were done by
the more experienced surgeons in the group. Our experience
demonstrates that EVAR can be done safely, with technical
results comparable with those obtainable with IC.
The degree and rate of deterioration in renal function
following EVAR remains poorly defined. A large EVAR
study showed a concerning 10% average decrease in creat-
inine clearance during the first year following surgery.11
However, another sizable study revealed a slight recovery in
renal function during the second year following surgery,
but without return to preoperative levels.12 A recent suba-
nalysis of the EVAR I and II trials suggests that the rate of
decrease in GFR following EVAR is slow, and that the
increased rate in deterioration in renal function following
EVAR is associated with endograft complications.13 A
plausible explanation for this association may be the admin-
istration of IC required for the additional imaging and
endovascular procedures required for the management of
such complications. This may be yet another compelling
reason to avoid IC in EVAR patients. Interestingly, these
three referenced studies suggest that the presence of renal
insufficiency prior to EVAR is not associated with an in-
creased risk of long-term renal dysfunction. This finding is
counterintuitive, since pre-existing renal insufficiency is a
major predictor of postoperative renal failure in patients
undergoing EVAR, and renal failure itself is associated with
a significant increase in hospital mortality.14,15
Our data suggest that CO2-guided EVAR in patients
with pre-existing moderate to severe renal dysfunction
(class 3 and 4 of the NKF classification) was associated with
no change in GFR, while patients undergoing EVAR with
IC sustained a significant postoperative reduction in GFR.
This is an observation that we have not found described in
the literature and that strongly suggests that CO2 elimi-
nates the renal toxicity associated with IC in EVAR pa-
tients. A significant weakness of our study is that our
patients were not routinely followed long term with eGFR
measurements, so we cannot evaluate the duration of renal
protection following CO2-guided EVAR. Unfortunately,
the long-term renal protective effects of IC avoidance during
EVARmay be counteracted by the large number of contrast-
enhanced diagnostic and interventional procedures that these
patients endure during long-term follow-up. The ideal renal
protection policywould therefore have to include not only the
avoidance of intraoperative IC but also the use of noncontrast
methods for surveillance, such as ultrasound or unenhanced
CT. The following rhetorical question may serve as an appro-
priate closing statement: If the technical success, morbidity-
mortality, and follow-up results of CO2-guided EVAR are
comparable with those obtained using IC, why should we
continue to use the nephrotoxic agent? SUTHOR CONTRIBUTIONS
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